Novo Nordisk's future in doubt after Wegovy maker's 'surprise' CEO ouster
Novo Nordisk's ousting of longtime CEO Lars Fruergaard Jørgensen bemused analysts, with many questioning the future of the Wegovy obesity drug maker.
You are not logged in so some information on this page has been withheld. To see more, please log in.
CEO Lars Fruergaard
since
auto-detected in 109 stories
15 days ago
page 1 of 1